NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Therapeutic Diets in Alzheimer's Disease
Therapeutic Diets in Alzheimer's Disease

NCT03860792

CompletedNA

Sponsor: University of Kansas Medical Center

Conditions: Alzheimer Disease

Interventions: Ketogenic Diet, Therapeutic Lifestyles Changes Diet

Countries: United States

By doing this study, researchers hope to learn how the ketogenic and Therapeutic Lifestyles Changes diets affect cognition in patients with Alzheimer's disease.

Eligibility overview

Sex: ALL

Age: 50 Years to 90 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Diagnosis of AD by current McKhann et al. criteria
* CDR global score of 0.5 or 1
* Agreed cooperation from an appropriate study partner
* Speaks English as primary language
* Age 50 to 90
* No medication changes within the past 30 days

Exclusion Criteria:

* Resides in a nursing home or dementia special care unit, or cannot control diet
* A potentially confounding serious medical risk including insulin-requiring diabetes, cancer requiring chemotherapy or radiation within the past 5 years, or a recent cardiac event (i.e. heart attack, angioplasty, etc.)
* Participating in another clinical trial or using an investigational drug or therapy within 30 days of the Screening Visit
* A history of renal stones
Locations (1)
  • Fairway, Kansas, United States